Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Neonatal Hypoglycaemia Management Guideline appraisal using the AGREE II instrument and report of variations in unit guidelines in Australia and New Zealand
NNeeoonnaattaall HHyyppooggllyyccaaeemmiiaa MMaannaaggeemmeenntt GGuuiiddeelliinnee aapppprraaiissaall uussiinngg tthhee AAGGRREEEE IIII iinnssttrruummeenntt aanndd rreeppoorrtt ooff vvaarriiaattiioonnss iinn uunniitt gguuiiddeelliinneess iinn AAuussttrraalliiaa aanndd NNeeww ZZeeaallaanndd

Neonatal Hypoglycaemia Management Guideline appraisal using the AGREE II instrument and report of variations in unit guidelines in Australia and New Zealand

J Paediatr Child Health. 2024 Dec 2. doi: 10.1111/jpc.16729. Online ahead of print.

ABSTRACT

AIM: To assess the quality and rigour of Neonatal Hypoglycaemia guidelines used in the major Australian and New Zealand neonatal care centres. To compare and highlight any major differences in management guidelines between centres.

METHODS: All level III NICUs in Australia and New Zealand were invited to participate. The AGREE II (Appraisal of Guidelines, Research & Evaluation) was used to critically appraise the guideline for the management of neonatal hypoglycaemia. Recommendations regarding definition, treatment, method of testing and admission criteria were compared from the guidelines provided.

RESULTS: Neonatal Hypoglycaemia guidelines were received from 19 of the 29 invited hospitals; two guidelines were excluded as the hospitals providing these guidelines did not provide care for inborn neonates. None of the 17 guidelines received a standardised score of 50% or higher on all six domains of the AGREE II tool. The mean scores of each of the AGREE II domains were as follows: Scope and Purpose 76%; Stakeholder Involvement 41%; Rigour of Development 20%; Clarity of Presentation 66%; Applicability 30% and Editorial Independence 0.1%. The glycaemic threshold defining hypoglycaemia varied between 2.0 and 2.6 mmol/L in the guidelines. True blood glucose using either a glucose oxidase method or blood gas analyser was recommended as the first line test in 35% of the guidelines. Fifteen of the 17 guidelines recommended buccal gel as first-line treatment of hypoglycaemia.

CONCLUSIONS: Neonatal Hypoglycaemia guidelines are of varying methodological quality. There are inconsistences in the management of hypoglycaemia across neonatal units in Australia and New Zealand.

PMID:39620315 | DOI:10.1111/jpc.16729